Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

To Rebuild Zicam, Matrixx Can Tap Into Brand's History, Pharmacists' Regard

This article was originally published in The Tan Sheet

Executive Summary

Matrixx Initiatives' best chances for rebuilding the Zicam brand appear to be reminding consumers why they initially chose the firm's products and tapping pharmacists' insight on the efficacy of zinc-containing cold remedies
Advertisement

Related Content

Odds Are Stacked Against Matrixx In Bid To Rescind Zicam Warning Letter
Odds Are Stacked Against Matrixx In Bid To Rescind Zicam Warning Letter
Odds Are Stacked Against Matrixx In Bid To Rescind Zicam Warning Letter
McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs
McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs
Matrixx Banks On Oral Cold Remedies And A Severe Flu Season
Matrixx Launches Zicam Products To Rebound During Cold Season
Matrixx Launches Zicam Products To Rebound During Cold Season
FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule
Motrin Viral Ad Reveals Perils Of Targeted Digital Marketing

Topics

Advertisement
UsernamePublicRestriction

Register

PS103626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel